Published in Scand J Immunol on May 01, 2010
MicroRNAs in Human Diseases: From Cancer to Cardiovascular Disease. Immune Netw (2011) 1.29
Altered miR-146a expression in Sjögren's syndrome and its functional role in innate immunity. Eur J Immunol (2011) 1.22
Genetic association of miRNA-146a with systemic lupus erythematosus in Europeans through decreased expression of the gene. Genes Immun (2012) 1.16
Semi-supervised learning for potential human microRNA-disease associations inference. Sci Rep (2014) 1.16
MicroRNA-146a: A Dominant, Negative Regulator of the Innate Immune Response. Front Immunol (2014) 1.15
Association of ORAI1 haplotypes with the risk of HLA-B27 positive ankylosing spondylitis. PLoS One (2011) 1.07
microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma. Mol Cancer (2015) 0.99
Altered spinal microRNA-146a and the microRNA-183 cluster contribute to osteoarthritic pain in knee joints. J Bone Miner Res (2013) 0.95
IRAK1 rs3027898 C/A polymorphism is associated with risk of rheumatoid arthritis. Rheumatol Int (2012) 0.93
MicroRNAs in Human Diseases: From Autoimmune Diseases to Skin, Psychiatric and Neurodegenerative Diseases. Immune Netw (2011) 0.90
Association of microRNA-146a and its target gene IRAK1 polymorphism with enthesitis related arthritis category of juvenile idiopathic arthritis. Rheumatol Int (2014) 0.87
Role of Micro RNAs in the Pathogenesis of Rheumatoid Arthritis: Novel Perspectives Based on Review of the Literature. Medicine (Baltimore) (2015) 0.86
The association between susceptibility to inflammatory arthritis and miR-146a, miR-499 and IRAK1 polymorphisms. A meta-analysis. Z Rheumatol (2015) 0.83
Common MIR146A Polymorphisms in Chinese Ankylosing Spondylitis Subjects and Controls. PLoS One (2015) 0.81
RNASEL and MIR146A SNP-SNP interaction as a susceptibility factor for non-melanoma skin cancer. PLoS One (2014) 0.80
Association of interleukin-1 receptor-associated kinase (IRAK1) gene polymorphisms (rs3027898, rs1059702) with systemic lupus erythematosus in a Chinese Han population. Inflamm Res (2013) 0.80
Association between IRAK1 rs3027898 and miRNA-499 rs3746444 polymorphisms and rheumatoid arthritis : A case control study and meta-analysis. Z Rheumatol (2016) 0.79
Meta-analysis of microRNA-146a rs2910164 G>C polymorphism association with autoimmune diseases susceptibility, an update based on 24 studies. PLoS One (2015) 0.79
An Exploration of the Role of MicroRNAs in Psoriasis: A Systematic Review of the Literature. Medicine (Baltimore) (2015) 0.78
MiR-146a suppresses hepatocellular carcinoma by downregulating TRAF6. Am J Cancer Res (2016) 0.77
Predicting the potential ankylosing spondylitis-related genes utilizing bioinformatics approaches. Rheumatol Int (2014) 0.76
Identification of plasma microRNA expression profile in radiographic axial spondyloarthritis-a pilot study. Clin Rheumatol (2015) 0.75
The Role of MicroRNAS in Ankylosing Spondylitis. Medicine (Baltimore) (2016) 0.75
Post-transcriptional control of cytokine gene expression in health and disease. J Interferon Cytokine Res (2014) 0.75
The Emerging Role of Epigenetics in Autoimmune Thyroid Diseases. Front Immunol (2017) 0.75
Hsa-mir-499 rs3746444 T/C Polymorphism is Associated with Increased Risk of Coronary Artery Disease in a Chinese Population. Acta Cardiol Sin (2017) 0.75
Polymorphisms in miRNA genes and their involvement in autoimmune diseases susceptibility. Immunol Res (2017) 0.75
Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST-RA database. Ann Rheum Dis (2009) 2.61
European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis (2001) 2.49
Arrayed primer extension: solid-phase four-color DNA resequencing and mutation detection technology. Genet Test (2000) 2.01
Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis. Ann Rheum Dis (2004) 1.73
Patients with anticentromere antibodies, clinical features, diagnoses and evolution. Br J Rheumatol (1993) 1.64
Radiographic evidence of disease progression in methotrexate treated and nonmethotrexate disease modifying antirheumatic drug treated rheumatoid arthritis patients: a meta-analysis. J Rheumatol (1992) 1.56
Remission, relapse, and re-remission of proliferative lupus nephritis treated with cyclophosphamide. Kidney Int (2000) 1.50
Increased prevalence of anti-thyroid antibodies in patients with limited scleroderma. Scand J Rheumatol (2011) 1.41
Apolipoprotein E polymorphisms and ischaemic stroke: a two-center Greek study. Eur J Neurol (2014) 1.41
Investigation for the presence of anti-erythropoietin antibodies in patients with myelodysplastic syndromes. Eur J Haematol (2001) 1.40
Induction of psoriatic skin lesions in a patient with rheumatoid arthritis treated with rituximab. Clin Exp Rheumatol (2010) 1.40
Cyclosporine A in the treatment of early rheumatoid arthritis. A prospective, randomized 24-month study. Clin Exp Rheumatol (1999) 1.39
Necrotizing vasculitis in Greece: clinical, immunological and immunogenetic aspects. A study of 66 patients. Br J Rheumatol (1997) 1.39
Uterine cervical involvement in a patient with Wegener's granulomatosis. Am J Med (2000) 1.38
Preliminary diagnostic criteria for Sjögren's syndrome. Scand J Rheumatol Suppl (1986) 1.37
Laryngeal involvement in rheumatoid arthritis. Rheumatol Int (2005) 1.36
Immune-mediated skin lesions in patients treated with anti-tumour necrosis factor alpha inhibitors. Scand J Rheumatol (2009) 1.34
Kidney involvement in primary Sjögren's syndrome. Scand J Rheumatol Suppl (1986) 1.33
Epidemiology of primary Sjögren's syndrome in north-west Greece, 1982-2003. Rheumatology (Oxford) (2005) 1.23
Role of cytokines in the pathogenesis of anemia of chronic disease in rheumatoid arthritis. Clin Immunol (1999) 1.17
Epidemiology of adult rheumatoid arthritis in northwest Greece 1987-1995. J Rheumatol (1997) 1.16
Pulmonary involvement in patients with early rheumatoid arthritis. Scand J Rheumatol (2007) 1.13
Does cigarette smoking influence disease expression, activity and severity in early rheumatoid arthritis patients? Clin Exp Rheumatol (2006) 1.12
Efficacy and safety of switching from infliximab to adalimumab: a comparative controlled study. Ann Rheum Dis (2005) 1.12
Outcome of lupus pregnancy: a controlled study. Rheumatology (Oxford) (2000) 1.12
Renal tubular acidosis in primary Sjögren's syndrome. Clin Rheumatol (1992) 1.11
Erythema nodosum: the underlying conditions. Clin Rheumatol (2000) 1.11
Demonstration and identification of monoclonal proteins in the urine of patients with Sjögren's syndrome. Ann Rheum Dis (1985) 1.09
Anticardiolipin antibodies in unselected autoimmune rheumatic disease patients. Clin Immunol Immunopathol (1987) 1.07
Visceral leishmaniasis resembling systemic lupus erythematosus. Ann Rheum Dis (2004) 1.06
Systemic lupus erythematosus in Greece. Clinical features, evolution and outcome: a descriptive analysis of 292 patients. Lupus (1993) 1.06
European multicentre study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centres. Ann Rheum Dis (2001) 1.04
The spectrum of neurological involvement in Sjögren's syndrome. Br J Rheumatol (1990) 1.03
Cutaneous vasculitis as the initial manifestation in acute myelomonocytic leukemia. Ann Intern Med (1994) 1.03
Chromomycin A3-staining as an indicator of protamine deficiency and fertilization. Int J Androl (1996) 1.00
Secondary Sjögren's syndrome in rheumatoid arthritis. J Rheumatol (1987) 1.00
Epidemiology of ankylosing spondylitis in Northwest Greece, 1983-2002. Rheumatology (Oxford) (2004) 1.00
Urticaria and angiedema-like skin reactions in a patient treated with adalimumab. Clin Rheumatol (2006) 1.00
Clinical course and outcome of early rheumatoid arthritis. Rheumatol Int (2001) 0.99
Enzyme immunoassays for the detection of IgG and IgM anti-dsDNA antibodies: clinical significance and specificity. Clin Exp Rheumatol (1988) 0.98
Molecular screening of fragile X (FRAXA) and FRAXE mental retardation syndromes in the Hellenic population of Greece and Cyprus: incidence, genetic variation, and stability. Am J Med Genet (1999) 0.98
Pulmonary function of nonsmoking patients with systemic lupus erythematosus. Chest (1988) 0.97
Infliximab treatment in combination with cyclosporin A in patients with severe refractory rheumatoid arthritis. Ann Rheum Dis (2002) 0.97
Gender, body mass index and rheumatoid arthritis disease activity: results from the QUEST-RA Study. Clin Exp Rheumatol (2010) 0.97
Hearing loss in Sjögren's syndrome patients. A comparative study. Clin Exp Rheumatol (2001) 0.96
Gender and age differences in systemic lupus erythematosus. A study of 489 Greek patients with a review of the literature. Lupus (2002) 0.96
The genetic basis of polycystic ovary syndrome. Eur J Endocrinol (2002) 0.96
Assessment of gastrointestinal involvement. Clin Exp Rheumatol (2003) 0.96
Cyclosporin A (CyA) in primary Sjögren's syndrome: a double blind study. Ann Rheum Dis (1986) 0.95
Soluble interleukin 2 receptor molecules in the serum of patients with autoimmune diseases. Clin Immunol Immunopathol (1989) 0.95
Association of oestrogen receptor alpha polymorphisms and androgen receptor CAG trinucleotide repeats with male infertility: a study in 109 Greek infertile men. Int J Androl (2002) 0.95
The role of sex hormone-binding globulin and androgen receptor gene variants in the development of polycystic ovary syndrome. Hum Reprod (2008) 0.95
Severity of cardiovascular disease in postmenopausal women: associations with common estrogen receptor alpha polymorphic variants. Eur J Endocrinol (2007) 0.94
Psychiatric symptoms associated with scleroderma. Psychother Psychosom (2001) 0.93
Reappraisal of respiratory abnormalities in primary and secondary Sjögren's syndrome. A controlled study. Chest (1986) 0.93
Granuloma annulare induced by anti-tumour necrosis factor therapy. Ann Rheum Dis (2007) 0.93
Xerotrachea and interstitial lung disease in primary Sjogren's syndrome. Respiration (1984) 0.92
Sjögren's syndrome in systemic lupus erythematosus. J Rheumatol (1990) 0.92
The gastrointestinal involvement in primary Sjögren's syndrome. Scand J Rheumatol Suppl (1986) 0.92
Healing of psoriatic skin lesions, and improvement of psoriatic arthritis resistant to immunosuppressive drugs, after infliximab treatment. Ann Rheum Dis (2005) 0.92
Antibodies to cellular antigens in Greek patients with autoimmune rheumatic diseases: anti-Ro(SSA) antibody a possible marker of penicillamine-D intolerance. Ann Rheum Dis (1984) 0.91
Obesity, adipose tissue and rheumatoid arthritis: coincidence or more complex relationship? Clin Exp Rheumatol (2011) 0.91
Inner ear involvement in rheumatoid arthritis: a prospective clinical study. J Laryngol Otol (1995) 0.91
HLA class II sequence polymorphisms and susceptibility to rheumatoid arthritis in Greeks. The HLA-DR beta shared-epitope hypothesis accounts for the disease in only a minority of Greek patients. Arthritis Rheum (1992) 0.91
Oral pilocarpine for the treatment of ocular symptoms in patients with Sjögren's syndrome: a randomised 12 week controlled study. Ann Rheum Dis (2003) 0.91
A multichannel watershed-based segmentation method for multispectral chromosome classification. IEEE Trans Med Imaging (2008) 0.90
Oral focal epithelial hyperplasia. Eur J Dermatol (2000) 0.90
Infliximab therapy in patients with ankylosing spondylitis: an open label 12 month study. Ann Rheum Dis (2003) 0.90
Association of SHBG gene polymorphism with menarche. Mol Hum Reprod (2005) 0.90
Combined estrogen receptor alpha and estrogen receptor beta genotypes influence the age of menarche. Hum Reprod (2005) 0.90
Efforts to create an artificial testis: culture systems of male germ cells under biochemical conditions resembling the seminiferous tubular biochemical environment. Hum Reprod Update (2005) 0.89
Survival of TNF-alpha antagonists in rheumatoid arthritis: a long-term study. Clin Exp Rheumatol (2012) 0.89
Novel universal approach for preimplantation genetic diagnosis of beta-thalassaemia in combination with HLA matching of embryos. Hum Reprod (2004) 0.89
Lymphoma in Sjogren's syndrome. Med Pediatr Oncol (1992) 0.89
Seckel syndrome in a family with three affected children and hematological manifestations associated with chromosome instability. Genet Couns (1995) 0.89
Treatment of resistant rheumatoid arthritis by intra-articular infliximab injections: a pilot study. Ann Rheum Dis (2004) 0.88
The role of psychological distress and personality variables in the disablement process in rheumatoid arthritis. Scand J Rheumatol (2009) 0.87
Open versus closed oocyte vitrification system: a prospective randomized sibling-oocyte study. Reprod Biomed Online (2013) 0.87
Sjögren's syndrome in rheumatoid arthritis and progressive systemic sclerosis. A comparative study. Clin Exp Rheumatol (1989) 0.87
Infliximab treatment in ankylosing spondylitis: an observational study. Ann Rheum Dis (2004) 0.87
PGD for autosomal dominant polycystic kidney disease type 1. Mol Hum Reprod (2004) 0.86
Altered sequence of the ETS1 transcription factor may predispose to rheumatoid arthritis susceptibility. Scand J Rheumatol (2012) 0.86